Registration is now open for the National Home Infusion Association’s 2023 Annual Conference (NHIA 2023), to be held March 25-29, 2023, at the Gaylord National Resort & Convention Center in Washington, D.C.
NHIA member pharmacies began reporting that TRICARE patients had received letters from Express Scripts stating the local home infusion pharmacy they currently use will not be in network as of October 24, 2022. NHIA sent a letter to Defense Health Agency and Express Scripts requesting the repeal of any network pharmacy cancellations.
The National Home Infusion Association (NHIA) was honored as a “COVID Hero of New York” by NewYorkBIO, a group that brings together nearly 300 of the state’s bioscience companies, universities, research institutions, and others dedicated to advancing life science research and commercialization.
NHIA submitted comments pointing out the advantages of home-based administration of subcutaneous Ig (SCIG) for chronic inflammatory demyelinating polyneuropathy (CIPD).
Support NHIF and Infuse Wellness this October into your life and others. There are many ways to participate—get together with your colleagues and form a team to compete against the NHIA staff and other members.
NHIA committees bring together thought leaders and innovators to complement and support staff efforts to promote and achieve the association’s mission.
NHIA submitted comments on a CMS proposed rule (CMS-1770-P) that would affect Medicare payments and coverage of COVID-19 vaccines and monoclonal antibodies (mAbs) and coding and billing requirements related to the use of single dose containers and drug waste.
Dozens of health systems, hospitals, and group purchasing organizations are calling on Congress to address Medicare beneficiary access to home infusion services and pass legislation that would increase access to home-based care, urging congressional leaders to advance the Preserving Patient Access to Home Infusion Act (S. 2652/H.R. 5067) to encourage access to home infusion therapy for Medicare beneficiaries.
The National Home Infusion Association (NHIA) will hold its first-ever home and specialty infusion payor summit November 2 in Dallas, TX. The event is designed to bring together leaders from commercial health insurance plans with home and specialty infusion experts to discuss how payors can better leverage home infusion to lower the total cost of care.
As part of a strategic focus on promoting health equity, The National Home Infusion Foundation (NHIF) recently adopted standardized categories for race and ethnicity data collection and is encouraging all providers to include voluntary questions to capture this data. NHIF will utilize this data throughout its projects to evaluate equitable access to infusion treatments in alternate sites.
Rep. Earl L. “Buddy” Carter (R-GA.), one of two pharmacists in Congress, penned an op-ed, “Four years later, Medicare policy is still failing home infusion therapy patients” recently published in The Hill. The article highlights flaws in CMS’ implementation of the Home Infusion Therapy Services benefit that is limiting access to these services.
Connect to the NHIA Community on the go by using the Connected Community mobile app, available for Apple or Android. Browse an activity feed of the latest going on across your communities, post and reply to discussion threads, search for resources and other content, and send and receive messages from other users.
Review the list of the top discussion topics to gain insight from professionals from around the NHIA Community on the most pertinent and timely issues of the past year. Learn what other infusion providers are considering and jump in to share your perspective as well!
The NHIA Community provides you several ways to be notified of updates in the community, allowing you to adjust the frequency and format of your notifications. This way you know, on your schedule, when new discussion posts and replies are added or when there is other news or announcements.
The NHIA Community has officially been supporting and connecting our members for one year. Although this is still just the early days of this incredible resource for the home and alternate site infusion industry, we have seen some amazing things during year one and have a lot more planned to continue to improve the platform and what it offers NHIA members.
Mark Wiencek, PhD, Contec, Inc.; Michael Bedenbaugh, PharmD, MBA, MS, Intramed Plus, Inc.; Lauren Pernot, BS, Contec, Inc.; Kate Douglass, MS, RN; Cognitive Design Associates
It is best practice to wipe down surfaces of supplies such as intravenous (IV) bags and vials packaged in cardboard boxes with a disinfectant before bringing the supplies into classified areas of a clean room. Effective decontamination of hazardous drug residues on containers such as IV bags may reduce the risk of occupational exposure. It is critical to understand the risk of penetration of any potential disinfecting or decontaminating agent into the IV bags.
Cheyenne Johnson, PharmD, Option Care Health; Daniel Decker, PharmD, MBA, BCACP, Option Care Health; Maria Giannakos, PharmD, MBA, BCPS, BCSCP, Option Care Health
Patients treated with intravenous (IV) vancomycin in the hospital often require outpatient parenteral antimicrobial therapy (OPAT) after discharge for the continuation of therapy. Despite vigilant monitoring, nephrotoxicity is a common adverse drug event associated with vancomycin in the home infusion setting.
Registration is now open for the National Home Infusion Association’s 2023 Annual Conference (NHIA 2023), to be held March 25-29, 2023, at the Gaylord National Resort & Convention Center in Washington, D.C.
NHIA member pharmacies began reporting that TRICARE patients had received letters from Express Scripts stating the local home infusion pharmacy they currently use will not be in network as of October 24, 2022. NHIA sent a letter to Defense Health Agency and Express Scripts requesting the repeal of any network pharmacy cancellations.
The National Home Infusion Association (NHIA) was honored as a “COVID Hero of New York” by NewYorkBIO, a group that brings together nearly 300 of the state’s bioscience companies, universities, research institutions, and others dedicated to advancing life science research and commercialization.
NHIA submitted comments pointing out the advantages of home-based administration of subcutaneous Ig (SCIG) for chronic inflammatory demyelinating polyneuropathy (CIPD).
Support NHIF and Infuse Wellness this October into your life and others. There are many ways to participate—get together with your colleagues and form a team to compete against the NHIA staff and other members.
NHIA committees bring together thought leaders and innovators to complement and support staff efforts to promote and achieve the association’s mission.
NHIA submitted comments on a CMS proposed rule (CMS-1770-P) that would affect Medicare payments and coverage of COVID-19 vaccines and monoclonal antibodies (mAbs) and coding and billing requirements related to the use of single dose containers and drug waste.
Dozens of health systems, hospitals, and group purchasing organizations are calling on Congress to address Medicare beneficiary access to home infusion services and pass legislation that would increase access to home-based care, urging congressional leaders to advance the Preserving Patient Access to Home Infusion Act (S. 2652/H.R. 5067) to encourage access to home infusion therapy for Medicare beneficiaries.
The National Home Infusion Association (NHIA) will hold its first-ever home and specialty infusion payor summit November 2 in Dallas, TX. The event is designed to bring together leaders from commercial health insurance plans with home and specialty infusion experts to discuss how payors can better leverage home infusion to lower the total cost of care.
As part of a strategic focus on promoting health equity, The National Home Infusion Foundation (NHIF) recently adopted standardized categories for race and ethnicity data collection and is encouraging all providers to include voluntary questions to capture this data. NHIF will utilize this data throughout its projects to evaluate equitable access to infusion treatments in alternate sites.
Rep. Earl L. “Buddy” Carter (R-GA.), one of two pharmacists in Congress, penned an op-ed, “Four years later, Medicare policy is still failing home infusion therapy patients” recently published in The Hill. The article highlights flaws in CMS’ implementation of the Home Infusion Therapy Services benefit that is limiting access to these services.
Connect to the NHIA Community on the go by using the Connected Community mobile app, available for Apple or Android. Browse an activity feed of the latest going on across your communities, post and reply to discussion threads, search for resources and other content, and send and receive messages from other users.
Review the list of the top discussion topics to gain insight from professionals from around the NHIA Community on the most pertinent and timely issues of the past year. Learn what other infusion providers are considering and jump in to share your perspective as well!
The NHIA Community provides you several ways to be notified of updates in the community, allowing you to adjust the frequency and format of your notifications. This way you know, on your schedule, when new discussion posts and replies are added or when there is other news or announcements.
The NHIA Community has officially been supporting and connecting our members for one year. Although this is still just the early days of this incredible resource for the home and alternate site infusion industry, we have seen some amazing things during year one and have a lot more planned to continue to improve the platform and what it offers NHIA members.
Mark Wiencek, PhD, Contec, Inc.; Michael Bedenbaugh, PharmD, MBA, MS, Intramed Plus, Inc.; Lauren Pernot, BS, Contec, Inc.; Kate Douglass, MS, RN; Cognitive Design Associates
It is best practice to wipe down surfaces of supplies such as intravenous (IV) bags and vials packaged in cardboard boxes with a disinfectant before bringing the supplies into classified areas of a clean room. Effective decontamination of hazardous drug residues on containers such as IV bags may reduce the risk of occupational exposure. It is critical to understand the risk of penetration of any potential disinfecting or decontaminating agent into the IV bags.
Cheyenne Johnson, PharmD, Option Care Health; Daniel Decker, PharmD, MBA, BCACP, Option Care Health; Maria Giannakos, PharmD, MBA, BCPS, BCSCP, Option Care Health
Patients treated with intravenous (IV) vancomycin in the hospital often require outpatient parenteral antimicrobial therapy (OPAT) after discharge for the continuation of therapy. Despite vigilant monitoring, nephrotoxicity is a common adverse drug event associated with vancomycin in the home infusion setting.
